Hybrigenics has extended its partnership with Servier to discover new drugs which inhibit Ubiquitin-Specific Proteases, or USPs. This partnership was initiated in October 2011.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0081 EUR | +1.25% |
|
-18.18% | -63.51% |
Jun. 04 | ITALY GROWTH WINNERS & LOSERS: Bullish plants; Aton Green at the back of the pack. | AN |
May. 07 | ATON board of directors chooses Uguzzoni as CEO and appoints Nervosi as vice chairman | AN |
1st Jan change | Capi. | |
---|---|---|
-63.51% | 3.55M | |
+6.62% | 216B | |
+10.99% | 189B | |
+27.18% | 153B | |
+32.69% | 114B | |
+1.71% | 63.2B | |
+18.26% | 54.78B | |
+1.63% | 48.47B | |
-2.84% | 38.88B | |
+1.98% | 36.14B |
- Stock Market
- Equities
- ALTAO Stock
- News ATON
- Hybrigenics Extends Partnership with Servier for USPs Inhibitors